Trippbio
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10151 Deerwood Park Blvd Ste 250 Bldg 20...Website
www.trippbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Trippbio
TrippBio, Inc. is a pioneering biotech company focused on developing innovative antiviral therapies to treat respiratory viruses, including COVID-19, influenza, and RSV. Their flagship product, PanCytoVir, has shown promising results in clinical trials, demonstrating both antiviral and anti-inflammatory properties. The company aims to enhance healthcare treatment and provide life-saving solutions to patients worldwide. TrippBio is committed to creating products with lower risk and higher efficacy to improve patient outcomes.Explore more
Trippbio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trippbio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Trippbio recently announced quarterly report
Product Launch: Get notified when Trippbio launches new products
Check out if Trippbio is spiking on competitors!
Check if Trippbio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Trippbio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Trippbio
Website visits: Recent activity has been detected on your website
Click to see if Trippbio had a recent Job posting/layoffs
Trippbio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Trippbio
Compare insights from companies similar to Trippbio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Trippbio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trippbio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trippbio.
Trippbio Tech Stack
A closer look at the technologies used by Trippbio
Trippbio News & Media
TrippBio Presents at the World Vaccine Congress West Coast 2023 Meeting
PanCytoVir™ showed 100% protection against lethal H5N1 infection in mice, the complete elimination of infectious virus and a greater reduction of inflammation JACKSONVILLE, FL, UNITED STATES, November 29, 2023 /EINPresswire.com/ -- TrippBio, Inc. ( …TrippBio Announces Clearance of Investigational New Drug Application for PanCytoVir™ Treatment of Influenza
• First study will evaluate the pharmacokinetics of a novel oral PanCytoVir™ suspension JACKSONVILLE, FL, UNITED STATES, September 21, 2023 /EINPresswire.com/ -- TrippBio, Inc. (TrippBio), a clinical development-stage biopharmaceutical company …TrippBio Submits an Investigational New Drug Application to the U.S. FDA for PanCytoVir™ Treatment of Influenza
First study will evaluate the pharmacokinetics of a novel oral PanCytoVir suspension JACKSONVILLE, FLORIDA, UNITED STATES, August 22, 2023 /EINPresswire.com/ -- TrippBio, Inc. (TrippBio), a clinical development-stage biopharmaceutical company developing …TrippBio Announces Results of a Phase 2 Study of PanCytoVir™ in Patients with Mild-to-Moderate COVID-19
• Potent antiviral efficacy observed • Treatment with PanCytoVir™ resulted in a significant increase in the proportion of patients completely free of symptoms JACKSONVILLE, FL, USA, July 6, 2023 /EINPresswire.com/ -- TrippBio, Inc. (TrippBio), a …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trippbio
Sign Up For FreeTo access detailed company insights
TrippBio, Inc. is a pioneering biotech company focused on developing innovative antiviral therapies to treat respiratory viruses, including COVID-19, influenza, and RSV. Their flagship product, PanCytoVir, has shown promising results in clinical trials, demonstrating both antiviral and anti-inflammatory properties. The company aims to enhance healt... Read More
